Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Emami Gains in Mumbai on Paras Pharma Stake Purchase Report

Don't Miss Out —
Follow us on:

Dec. 2 (Bloomberg) -- Emami Ltd. gained as much as 7.3 percent in Mumbai trading after the Times of India newspaper reported the company may buy a majority stake in Ahmedabad-based Paras Pharmaceuticals Ltd. for 30 billion rupees.

Emami’s Managing Director Sushil Goenka couldn’t immediately be reached at his office telephone for comment on the report.

Link to Company News:{HMN IN <Equity> CN <GO>}

To contact the reporter on this story: Hemal Savai in Mumbai at

To contact the editor responsible for this story: Tuhin Kar at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.